ECF Research wins Best of IJO Award!

In January of 2018, ECF fellow Dr. Sonal Chaugule, alongside Dr. Paul Finger and Dr. J. Park, published the study “Topical Chemotherapy for Giant Ocular Surface Squamous Neoplasia (OSSN) of the Conjunctiva and Cornea: Is Surgery Really Necessary?” in the Indian Journal of Ophthalmology (IJO). We are pleased to announce that this research has recently been chosen for the Best of IJO Awards!

A feature at the recent International Society for Ophthalmic Oncology (ISOO) 2019 meeting, the 2017 American Academy of Ophthalmology (AAO) meeting, as well as our very own blog and Visionary newsletter, the study showed the surprising efficacy of chemotherapy eye drops. They found that even large squamous cancers of the conjunctiva can be cured with chemotherapy eye drops alone (no surgery). The drops had marvelous results: no evidence of vision-limiting complications, no tumor recurrences, and no patients required additional treatment for their giant OSSN. For all patients in the study, their cancer was cured, proving to researchers that topical chemotherapy drops were not only safe, but also effective as treatment for “giant” OSSN.

Congratulations, Dr. Chaugule!


To read the full study, click here.

To help sponsor ECF research and charitable endeavors, click here.

Squamous Carcinoma of the Eyelid

By Paul T. Finger, MD


Note the relatively flat surface, red (indurated – inflammed edges, and the white flakey material on the right side of its surface.


Squamous carcinomas of the eyelid can locally invade the orbit and sinuses, but rarely metastasizes. It is the second most common malignant eyelid tumor, but is 10 times less common than basal cell carcinoma. This should not be confused with conjunctival squamous carcinoma, which is the most common conjunctival cancer and can spill over onto the eyelid skin.


Squamous eyelid carcinoma can have symptoms that range from the appearance of a hypervascular flat pale, reddish or flaky lesion on the eyelid skin to a thickened well-demarcated reddish, flat tumor surrounded by inflammation (with or without scaling from its surface).


Squamous carcinoma of the eyelid should be photographed at baseline. These lesions can remain unchanged (for years), then invade into the dermis and grow. A simple wedge biopsy can be performed and sent for pathologic evaluation. Once the diagnosis of squamous carcinoma is biopsy proven, definitive treatment is needed.


Like basal cell carcinomas, squamous cell cancers of the eyelid rarely metastasize. However, they can grow around the eye into the orbit, sinuses and brain. Therefore, early intervention with complete excision or destruction is warranted.

Surgical approaches depend on the doctors training. Eye care specialists will either perform a planned excision with frozen-section control (of the margins) or the Moh’s Technique. Both types of surgery are used to remove the entire tumor along with a safety zone of normal appearing tissue from the edges of surgical wound (margins). No comparative studies have definitively shown that one technique better than the other. Both surgeries require a cosmetic surgical repair to return eyelid function and cosmesis. When the orbit and sinuses are not involved, local excision is usually curative.

Extension into the orbit and sinuses typically requires more extensive surgery (exenteration, sinusectomy) with subsequent radiation therapy.

At the New York Eye Cancer Center, we have treated select patients with small squamous carcinomas of the eyelid with topical chemotherapy agents or freezing (cryotherapy) using “Finger-tip” applicators. Dr. Finger tries to avoid surgery when possible.

Related links

Patient Stories

"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”

Read More


Go to Appointment Form